Turkey: Turkey Aligns Its Medical Device Regulation With The EU Regulation

Last Updated: 8 January 2019
Article by Gönenç Gürkaynak Esq, Ceren Yıldız and Nazlı Gürün
Most Read Contributor in Turkey, September 2019

In May 2017, Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices ("EU Regulation") entered into force, stipulating a transition period for medical device manufacturers to comply with the EU Regulation by May 2020.1 As the title of the EU Regulation suggests,2 it lays down enhanced rules on medical devices, manufacturers, distributors, importers, and notified bodies. For any medical device to be put into and sold on the market, full compliance with the EU Regulation is required. The EU Regulation introduces and addresses several new principles and renders procedures pertaining to medical devices more transparent, trackable and predictable. These changes aim to ensure a high level of safety and protection for patient health and for the users within this industry, also taking into consideration the technological evolution and developments in this field.

In Turkey, the Medical Device Regulation, which is based on the Council Directives 90/385/EEC and 93/42/EEC and which entered into force on June 7, 2011, is currently still in force and effect. Recently, a draft Medical Device Regulation ("Draft Regulation") has been prepared and announced by the Turkish Ministry of Health, with the intention and purpose of harmonizing and aligning the Turkish regulatory framework for medical devices with the new EU regulations.3

The Draft Regulation contains requirements that are in parallel (indeed, almost identical) to those put forth by the EU Regulation, while also addressing a few local issues and principles that are specific to Turkey. A translated version of the EU Regulation was first published on the official website of the Turkish Medicines and Medical Devices Agency ("Agency"), the authorized body for the enforcement of the Draft Regulation, and was opened to public comment in order to receive and gather opinions from interested parties. Subsequently, the Draft Regulation was published on the Agency's official website, requiring interested parties to convey their ideas, suggestions and comments to the Agency by November 16, 2018.

In this regard, it is safe to say that the Draft Regulation contains very similar regulations—even direct translations—to those set out in the EU Regulation. Accordingly, certain significant changes that have been introduced through the Draft Regulation are summarized below:

  • Addressing a critical issue, the Draft Regulation clearly prohibits labels, usage instructions and advertisements relating to a device's intended purpose, safety and performance from including misleading texts, names, trademarks, pictures, and figurative or other signs by (i) ascribing functions and properties to the device that the device does not possess, (ii) creating a false impression regarding any functions or properties related to treatment or diagnosis that the device does not have, (iii) failing to inform the user or patient of a potential risk associated with the use of the device in line with its intended purpose, and (iv) suggesting areas of use for the device other than those specified to form part of the intended purpose for which a conformity assessment has been carried out.
  • Another significant change introduced by the Draft Regulation pertains to the obligations of manufacturers, importers and distributors, as the current Medical Device Regulation (which is still in effect) contains several provisions with respect to manufacturers' obligations under a number of articles, but little to no regulation with respect to those of importers and distributors. In this regard, the obligations of manufacturers, importers and distributors are increased and become more detailed through the Draft Regulation. In this context, manufacturers are required to prepare and to regularly update the EU declaration of conformity. They are also required to fulfill their obligations with respect to (i) establishing a risk-management system, (ii) conducting a clinical evaluation for tracking their devices that have been put into market, (iii) preparing and updating the technical documentation of their devices, and (iv) establishing a quality-management system. Manufacturers must retain and have available at least one person within their organization who will be responsible for regulatory compliance, and who must possess specific qualifications. In the event that the manufacturer of a device does not reside in Turkey or in an EU Member State, the device may only be put into market by the authorized representative of the manufacturer. Increased and enhanced responsibilities have also been placed upon the importers and distributors of medical devices.
  • The Draft Regulation also comprises several changes in relation to the medical devices. While the product classifications remain the same, certain new procedures have been introduced with respect to the registration of the devices. The current Medical Device Regulation simply requires the Ministry of Health to ensure the local registration and evaluation of certain information pertaining to devices, whereas the Draft Regulation, parallel to the EU Regulation, introduces international registry systems, such as the Unique Device Identification (UDI) and EUDAMED schemes, on top of the local registration requirement.
  • The Draft Regulation also addresses issues relating to confidentiality and data protection, and requires the protection of personal data, commercially confidential and sensitive information, and information obtained during inspections, investigations, or audits.

As the notified bodies (which are currently authorized to grant the conformity certificate for medical devices to manufacturers) will also be required to meet and fulfill additional specifications in order to obtain their licenses and to continue operating, the Draft Communiqué on Notified Bodies Operating in the Medical Device Sector ("Draft Communiqué") has been prepared and published on the Agency's official website as well.4 The announcement of the Draft Communiqué also includes a comparison chart with the relevant articles of the EU Regulation, indicating that the Draft Communiqué has been prepared based on the EU Regulation.

The publication and enforcement dates of the Draft Regulation and the Draft Communiqué have yet to be announced. However, in light of the extensive similarity between the Draft Regulation and the EU Regulation, and considering that the EU Regulation provides a transition period of three years, we might reasonably anticipate that the Draft Regulation will stipulate a similar transition period for compliance after entering into legal force.


1  Please see http://data.europa.eu/eli/reg/2017/745/oj for the EU Regulation.

2  The full title of the EU Regulation is "Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC."

3  Please see http://titck.gov.tr/duyuru/3390 for the announcement and the draft regulation.

4  Please see http://titck.gov.tr/duyuru/3295 for the announcement and the draft.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
YukselKarkinKucuk Attorney Partnership
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Similar Articles
Relevancy Powered by MondaqAI
YukselKarkinKucuk Attorney Partnership
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions